AAAAAA
Results:
1-22
|
Results: 22
Authors:
Preisler, HD
Venugopal, P
Gregory, SA
Adler, S
Gezer, S
Hsu, WT
Manson, S
Larson, A
Jajeh, A
Slvinick, D
Galvez, A
Citation: Hd. Preisler et al., High remission rate in acute myeloblastic leukemia with only two days of chemotherapy, LEUK LYMPH, 41(3-4), 2001, pp. 333-336
Authors:
Tao, M
Li, BR
Nayini, J
Sivaraman, S
Song, SW
Larson, A
Toofanfard, M
Chen, H
Venugopal, P
Preisler, HD
Citation: M. Tao et al., In vivo effects of IL-4, IL-10, and amifostine on cytokine production in patients with acute myelogenous leukemia, LEUK LYMPH, 41(1-2), 2001, pp. 161-168
Authors:
Enschede, SH
Shahidi, H
Venugopal, P
Riley, MB
Huang, RW
Jajeh, A
Preisler, HD
Gregory, SA
Citation: Sh. Enschede et al., Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphoma, LEUK LYMPH, 40(3-4), 2001, pp. 325-334
Authors:
Preisler, HD
Li, B
Chen, H
Fisher, L
Nayini, J
Raza, A
Creech, S
Venugopal, P
Citation: Hd. Preisler et al., P15(INK4B) gene methylation and expression in normal, myelodysplastic, andacute myelogenous leukemia cells and in the marrow cells of cured lymphomapatients, LEUKEMIA, 15(10), 2001, pp. 1589-1595
Authors:
Preisler, HD
Perambakam, S
Li, B
Hsu, WT
Venugopal, P
Creech, S
Sivaraman, S
Tanaka, N
Citation: Hd. Preisler et al., Alterations in IRF1/IRF2 expression in acute myelogenous leukemia, AM J HEMAT, 68(1), 2001, pp. 23-31
Authors:
Devemy, E
Li, B
Tao, M
Horvath, E
Chopra, H
Fisher, L
Nayini, J
Creech, S
Venugopal, P
Yang, J
Kaspar, C
Hsu, WT
Preisler, HD
Citation: E. Devemy et al., Poor prognosis acute myelogenous leukemia: 3-biological and molecular biological changes during remission induction therapy, LEUK RES, 25(9), 2001, pp. 783-791
Authors:
Sivaraman, S
Venugopal, P
Ranganathan, R
Deshpande, CG
Huang, X
Jajeh, A
Gregory, SA
O'Brien, T
Preisler, HD
Citation: S. Sivaraman et al., Effect of interferon-alpha on CD20 antigen expression of B-cell chronic lymphocytic leukemia, CYTOK CELL, 6(2), 2000, pp. 81-87
Authors:
Preisler, HD
Li, B
Yang, J
Huang, RW
Devemy, E
Venugopal, P
Tao, M
Chopra, H
Gregory, SA
Adler, S
Sivaraman, S
Toofanfard, P
Jajeh, A
Galvez, A
Robin, E
Citation: Hd. Preisler et al., Suppression of telomerase activity and cytokine messenger RNA levels in acute myelogenous leukemia cells in vivo in patients by amifostine and interleukin 4, CLIN CANC R, 6(3), 2000, pp. 807-812
Authors:
Sivaraman, S
Deshpande, CG
Ranganathan, R
Huang, X
Jajeh, A
O'Brien, T
Huang, RW
Gregory, SA
Venugopal, P
Preisler, HD
Citation: S. Sivaraman et al., Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: A new role for TNF alpha?, MICROSC RES, 50(3), 2000, pp. 251-257
Authors:
Bi, S
Gao, XZ
Devemy, E
Chopra, H
Venugopal, P
Raza, A
Preisler, HD
Citation: S. Bi et al., Cytokine production by in vitro processed and unprocessed haematopoietic cells, CYTOKINE, 12(7), 2000, pp. 1124-1128
Authors:
Tao, M
Li, BR
Nayini, J
Andrews, CB
Huang, RW
Devemy, E
Song, SW
Venugopal, P
Preisler, HD
Citation: M. Tao et al., SCF, IL-1 beta, IL-1ra and GM-CSF in the bone marrow and serum of normal individuals and of AML and CML patients, CYTOKINE, 12(6), 2000, pp. 699-707
Authors:
Li, BR
Yang, J
Andrews, C
Chen, YX
Toofanfard, P
Huang, RW
Horvath, E
Chopra, H
Raza, A
Preisler, HD
Citation: Br. Li et al., Telomerase activity in preleukemia and acute myelogenous leukemia, LEUK LYMPH, 36(5-6), 2000, pp. 579-587
Authors:
Li, BR
Yang, J
Tao, M
Nayini, J
Horvath, E
Chopra, H
Meyer, PM
Venugopal, P
Preisler, HD
Citation: Br. Li et al., Poor prognosis acute myelogenous leukemia 2 - biological and molecular biological characteristics and treatment outcome, LEUK RES, 24(9), 2000, pp. 777-789
Authors:
Preisler, HD
Venugopal, P
Gregory, SA
Hsu, WT
Loew, J
Adler, S
Gezer, S
Creech, S
Galvez, A
Slivnick, D
Andric, T
Larson, RA
Jajeh, A
Citation: Hd. Preisler et al., Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine), LEUK RES, 24(8), 2000, pp. 671-680
Authors:
Venugopal, P
Sivaraman, S
Huang, XK
Nayini, J
Gregory, SA
Preisler, HD
Citation: P. Venugopal et al., Effects of cytokines on CD20 antigen expression on tumor cells from patients with chronic lymphocytic leukemia, LEUK RES, 24(5), 2000, pp. 411-415
Authors:
Mundle, SD
Mativi, BY
Cartlidge, JD
Dangerfield, B
Broady-Robinson, L
Li, BR
Shetty, V
Venugopal, P
Gregory, SA
Preisler, HD
Raza, A
Citation: Sd. Mundle et al., Signal antonymy unique to myelodysplastic marrows correlates with altered expression of E2F1, BR J HAEM, 109(2), 2000, pp. 376-381
Authors:
Preisler, HD
Gao, XZ
Ming, T
Li, BR
Bi, SC
Devemy, E
Loew, J
Raza, A
Citation: Hd. Preisler et al., Marrow cytokine transcripts and the secondary hematologic disorders, LEUK LYMPH, 35(3-4), 1999, pp. 297-302
Authors:
Mundle, S
Venugopal, P
Shetty, V
Ali, A
Chopra, H
Handa, H
Rose, S
Mativi, BY
Gregory, SA
Preisler, HD
Raza, A
Citation: S. Mundle et al., The relative extent and propensity of CD34(+) vs. CD34(-) cells to undergoapoptosis in myelodysplastic marrows, INT J HEMAT, 69(3), 1999, pp. 152-159
Authors:
Preisler, HD
Kauffman, S
Citation: Hd. Preisler et S. Kauffman, A proposal regarding the mechanism which underlies lineage choice during hematopoietic differentiation, LEUK RES, 23(8), 1999, pp. 685-694
Authors:
Preisler, HD
Citation: Hd. Preisler, Fitness landscapes and the myeloid leukemias, LEUK RES, 23(2), 1999, pp. 167-176
Authors:
Preisler, HD
Citation: Hd. Preisler, The treatment of the myelodysplastic syndromes, CANCER, 86(10), 1999, pp. 1893-1899
Authors:
Yang, J
Li, BR
Nayini, J
Venugopal, P
Tao, M
Andrews, CB
Preisler, HD
Citation: J. Yang et al., Tyrosine phosphorylation of Shc proteins in normal CD34(+) progenitor cells and leukemic cells, BLOOD, 94(1), 1999, pp. 373-374
Risultati:
1-22
|